Richi LifeSciences

07/30/2026

There is a massive difference between visiting the Boston biotech ecosystem and actually becoming a part of it. For Yaron Suissa, PhD, MBA and Walter Wasser, MD, co-founders of BDUK Therapeutics, the Richi LifeSciences Fall 2025 cohort was the catalyst that bridged that gap.

The program didn't just introduce BDUK to the market, it fundamentally upgraded how they operate as a business. With hands-on support from Richi LifeSciences’ team, Walter and Yaron sharpened their pitch deck, rebuilt their business model into a much stronger bio-commercial opportunity, and mastered how different investment vehicles, from VCs and angels to foundations and private equity, evaluate startups.

The real transformation, however, came from how they integrated locally. BDUK is no longer on the outside looking in.

"All of this enabled us to become part of the Boston bio-community," Walter G. Wasser, MD, CEO of BDUK Therapeutics says. "BDUK is now immersed in the ecosystem, we are working closely with many of the Boston bio-professionals, and the value we receive is enormous.”

“Importantly, all this would not have been achieved without the Richi team, professionals and really fun people to work with." adds Yaron Suissa, PhD, MBA COO and CTO of BDUK Therapeutics.

If your startup is driving innovation in Biotech, Medtech, Digital Health, or AI-Driven Healthcare, the next cohort of Richi LifeSciences is your gateway to this level of growth.

Apply today and join us in Boston from November 12th to 21st: https://www.richilifesciences.org/apply

📅 Want to learn more first?
Join our upcoming Executive Virtual Briefing to get all your questions answered.
🗓️ September 9th | 10:00 AM EDT / 4:00 PM CEST
👉 Register for the briefing here: https://www.richilifesciences.org/rls-call-projects-2627

07/14/2026

"There are few places equipped for successful launches toward unknown universes: Kennedy Space Center (Florida), Star City (Russia), Spaceport America (New Mexico) and Richi LifeSciences (Boston)."

That is how Myriam Laprise-Pelletier, CTO at Pharma in silica, describes her experience as one of our most recent alumni.

Based in Québec, Pharma in silica operates under a clear, powerful motto: "Poison the tumor, spare the patient." But translating complex precision chemotherapy into a venture-backed reality requires global market alignment. For Myriam, a researcher stepping into the business world, the program was a game-changer: "The intense immersion in the Boston ecosystem taught me, a scientist, the rhythms, inner workings, do's & don’ts, and jargon of life sciences financing."

During their nine days with Richi LifeSciences, the team realigned their financial strategy, and the demanding pitch training drastically elevated their storytelling. Their commitment paid off, and their footprint is officially planted: "We'll be back in Boston soon."

Now, it's your turn: Medtech, Digital Health, and AI-Driven Healthcare Innovation startups, Boston is your gateway to growth in the U.S. life sciences market, and the Fall 2026 edition of Richi LifeSciences is your bridge to get there. If you want the opportunity to connect and forge meaningful relationships with key innovation players, including investors, market leaders, industry experts, advisors, and both public and private institutions, apply now and accelerate your growth trajectory just like Pharma in silica did.

📆 Program Dates: November 12 – 20, 2026 | Boston, MA

🔗 Apply now: https://www.richilifesciences.org/

07/13/2026

Richi LifeSciences wants to meet you.

Boston remains the world’s leading life sciences ecosystem, offering unmatched access to capital, clinical networks, and market leaders. But for international startups, the real challenge is knowing how to successfully plug into it.

On September 9th, at 10am EDT | 4PM CEST, we are opening the doors. We are hosting a Virtual Executive Briefing designed for global leaders in Biotech, MedTech, Digital Health, and AI-Driven Healthcare who want to leverage Boston to accelerate U.S. and global growth.

During this session, we will share insights on how global startups can effectively enter and scale within this unique hub, and how the Richi LifeSciences platform acts as your gateway to Boston’s ecosystem and capital.

We are also actively scouting for our next programs: our upcoming confirmed Fall Edition on November 12–20, 2026, as well as our 2027 editions (dates TBD).

Learn what it takes to leverage Boston for your global growth. Secure your spot for this unique virtual executive briefing now.

🔗 https://www.richilifesciences.org/rls-call-projects-2627

07/01/2026

When Marta Dueñas (CEO at Danae Urogenomics) joined the Richi LifeSciences program in the fall of 2024, her team was just starting out on a massive mission: transforming diagnostics and precision medicine in bladder cancer through BlaDimiR, their innovative urine-based liquid biopsy platform. Thanks to the support of ITEMAS-Fundación Pfizer, who sponsored her spot in the program, Marta was able to bridge the gap between groundbreaking research and global market readiness.

Richi LifeSciences proved to be the exact catalyst Danae Urogenomics needed to shape their international roadmap. As Marta shares: "Participating in Richi LifeSciences has had a key impact on our journey: it helped us better understand the U.S. market, validate our international strategy, and connect with a highly valuable ecosystem."

Fast forward to today: Danae Urogenomics is successfully moving its roadmap forward. They are actively advancing the development and validation of their technology, while opening up powerful new collaboration opportunities to bring their platform closer to clinical practice, ultimately improving patient detection, stratification, and monitoring.

Now, it's your turn: Biotech, Medtech, Digital Health, and AI-Driven Healthcare Innovation startups, Boston is your gateway to growth in the U.S. life sciences market, and the Fall 2026 edition of Richi LifeSciences is your bridge to get there. Join us in Boston from November 12th to 20th, and accelerate your growth trajectory just like Marta did.

Apply Now: https://www.richilifesciences.org/

07/01/2026

🚨 Spanish Biotech Startups: The countdown is down to 48 hours! Don't miss your chance to join the Programa Desafía Boston Fall 2026 Edition. This exclusive immersion program, organized by ICEX and powered by Richi LifeSciences, is your gateway to the world's leading life sciences hub.

📆 Take note of the specific deadline: Applications close strictly on July 2nd at 15:00 CEST. Don't wait until the end of the day, or you'll miss the window!

If your Spanish biotech startup is ready to scale and considering expanding into the US market, this is your moment. From October 19th to 30th, you'll immerse yourself in Boston's elite ecosystem and connect with the key stakeholders, investors, and advisors who can power your venture forward.

The clock is ticking, and slots are limited. Complete your application today 👇
https://boston.desafia.icex.es/

06/24/2026

🚨Spanish biotech startups, don't forget to apply to Programa Desafía Boston Fall 2026 Edition!

There's only one week left to apply to this program led by ICEX and powered by Richi LifeSciences. We can't wait to meet all of you this October, and guide your immersion in the world's leading life sciences ecosystem.

🔗 Learn more and apply here: https://boston.desafia.icex.es/

⏳ Only 1 week left to apply for Programa Desafía Boston Fall 2026 Edition!

Are you a Spanish biotech looking to scale? Don’t miss your chance to join our fast-track immersion program in the world’s leading life sciences ecosystem.

From October 21st to 30th, selected companies will plug directly into Boston's elite network, connecting with key investors, industry experts, advisors, and top-tier market players.

🚀 An investment in your global scaling: To help you maximize this opportunity, Desafia fully backs the program costs, meaning you'll only need to cover your travel and accommodation.

Competition is fierce and slots are limited. Don’t wait until the last minute to secure your spot in Boston!

👉 Learn more and apply here: https://boston.desafia.icex.es/

ICEX Richi LifeSciences

06/16/2026

"Boston got it before Spain did."

When Patricia Puiggros MD, PhD (Founder & CEO of IKI Health Group) joined the Richi LifeSciences program in November 2023, her startup was an embryo. She arrived in the Boston winter with a half-built product, an open funding round, and a lot of chaos.

But Richi LifeSciences proved to be the pivotal turning point for IKI’s roadmap. It was during the program that they gained the validation and momentum needed to go global, receiving the advice that changed everything: "This is where you need to bring IKI. This market will get it."

Fast forward to today: IKI Health is actively scaling its global footprint. They were just back in Boston for Tech Week last month, running US pilots, and raising a $2M round with an American COO who found IKI through the very Boston ecosystem they integrated into two and a half years ago. As Patricia puts it: "Richi LifeSciences showed us that IKI belonged in Boston."

Now, it's your turn: Medtech, Digital Health, and AI-Driven Healthcare Innovation startups, Boston is your gateway to growth in the U.S. life sciences market, and the Fall 2026 edition of Richi LifeSciences is your bridge to get there. If you want the opportunity to connect and forge meaningful relationships with key innovation players, including investors, market leaders, industry experts, advisors, and both public and private institutions, apply now and accelerate your growth trajectory just like Patricia did.

📆 Program Dates: November 12 – 20, 2026

Don't wait for the right time. Build your bridge to Boston today.
👉 https://www.richilifesciences.org/

06/15/2026

Spanish Biotech Startups, don't miss your chance to join us in Boston this Fall! 🍂

From October 21st to 30th, Richi LifeSciences will be powering the third edition of Programa Desafía Boston. 🚀

Tune in this Wednesday, June 17th at 3pm CEST, for an informative webinar and get all the details before you apply to the program!

🔗 Save your spot now: https://www.icex.es/es/agenda/conferencia-desafia-boston-empresas-biotech-2026

Only 2 days left! ⏳ If you’ve been thinking about expanding your Spanish biotech startup into the Boston ecosystem, this is your chance to get the inside track.

Join us this Wednesday, June 17th at 3pm CEST for an informative session on the Programa Desafía Boston 2026.

What to expect:

•⁠ ⁠Direct insights from leadership at ICEX, the Spanish Economic & Commercial Offices in Boston and Chicago, and Richi LifeSciences.

•⁠ ⁠A full breakdown of the program’s structure, benefits, and timeline.

•⁠ ⁠A live Q&A session to sharpen your application ahead of the July 2nd deadline.

📅 When: Wednesday, June 17th at 3:00 PM (Spanish Time / CEST)
📍 Where: Online

Spaces are filling up. Grab your seat today!
https://www.icex.es/es/agenda/conferencia-desafia-boston-empresas-biotech-2026

05/28/2026

Applications are officially open for the Richi LifeSciences Fall 2026 Edition!

Immerse your company in Boston’s world-class life sciences ecosystem from November 12th–20th 🇺🇸

We are looking for forward-thinking startups and scale-ups in: Biotech, Medtech, Digital Health, and AI-Driven Healthcare Innovation.

To date, more than 150 companies from 20 countries have participated in the Richi LifeSciences program, establishing us as a fundamental catalyst in the global ecosystem. Building on this momentum, we recently played a pivotal role in launching a brand-new transatlantic biotech fund, co-led by the Richi Foundation.

As we continue to expand, our vision is to attract international capital across all life sciences verticals to boost your innovation globally through Boston.

👉 Apply now: https://www.richilifesciences.org/apply

📰 More information about the transatlantic biotech fund: https://www.bizjournals.com/boston/news/2026/04/14/spanish-government-200-million-venture-fund.html

11/24/2025

"Richi LifeSciences has been a game changer." That's the resounding feedback from this edition's cohort, and after two transformative weeks in Boston, we couldn't agree more!

The selected companies leave the program having successfully polished their pitches and gained hands-on strategies for US expansion. This second week focused intensely on launching in the US, mastering startup valuation, navigating legal and immigration regulation, and securing funding—including an essential negotiation workshop and a session on non-dilutive funds.

Participants met with numerous investors and industry experts who provided custom project feedback, and they toured state-of-the-art facilities like LabCentral and The Engine.

We extend a huge thank you to all the experts who made the final week so valuable: Robert Gottlieb, Joseph McKneely, Daniel Blanchard, Stan Chalvire, Valerie Vigoda, MBA, CIPP, Chuck Goldstone, Samuel (Mooly) Dinnar, Neal Kalechofsky, Rhett Smith, Felicia Gullotta, Jason Kraus, Ben Littauer, Shmuel Agus, Carles Monterrubio, PhD, Natalie Roy D'Amore, Tim Xu MD MPP, Doug Zingale, and Steve Pemberton.

Congratulations to this incredible cohort! We can't wait to see the breakthrough therapies and innovations you'll bring to patients!